Trial intelligence / Profile preview

Fruquintinib in Chinese metastatic colorectal cancer: real-world patient-reported outcomes and treatment outcomes

ChiCTR2100048106Phase 4Recruiting

Sponsor

Ruijin Hospital

Start

Jul 2021

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1